Inventor

DE BOER MARK

NL21 patents

⚠️ This page may combine multiple inventors who share the name “DE BOER MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DE BOER MARK

CHIRON CORP

Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation

Anti-CD40 monoclonal antibodies capable of blocking B-cell activation

CD40 antigen antibody complex

Methods of blocking B cell proliferation using anti-CD40 monoclonal antibodies

Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclonal antibodies

Methods of blocking B-cell activation using anti-CD40 monoclonal antibodies

Methods of blocking T-cell activation using anti-B7 monoclonal antibodies

Methods and materials for the induction of T cell anergy

PANGENETICS BV

CD40-binding activating antibodies

Gene constructs coding for CD40-binding activating antibodies

Induction of cytotoxic T lymphocyte responses using anti-CD40 antibodies

AKZO NOBEL NV

Process for preparing a large pore hydroprocessing catalyst

Catalyst comprising at least a hydrogenation metal component and a synthetic clay and a process of using

NOVARTIS VACCINES & DIAGNOSTIC

Anti-CD40 antibodies capable of blocking B-cell activation

Anti-CD40 antibodies capable of blocking B-cell activation

INNOGENETICS NV

Methods of treating autoimmune diseases with a CD86-specific immunotoxin

Immunotoxins specific for CD86 expressing cells

CETUS ONCOLOGY CORP

Method for generation of antibodies to cell surface molecules

(unassigned)

Process for preparing a hydroprocessing catalyst from waste hydroprocessing catalyst

NIPPON KETJEN CO LTD

Hydroprocessing catalyst and use thereof

DIABETES FREE INC

Antagonistic anti-human CD40 monoclonal antibodies